# Shanghai RAAS Blood Products Co., Ltd.
**Wikidata**: [Q106240969](https://www.wikidata.org/wiki/Q106240969)  
**Source**: https://4ort.xyz/entity/shanghai-raas-blood-products-co-ltd

## Summary
Shanghai RAAS Blood Products Co., Ltd., also known by its Chinese alias 上海莱士, is a publicly traded company. It is an enterprise that offers its securities, such as stocks or bonds, for sale to the general public. As a public company, its ownership is distributed among general shareholders rather than being confined to a closed group of private investors or a government agency.

## Key Facts
*   **Aliases:** 上海莱士
*   **Freebase ID:** /m/0cp7sz5
*   **Classification:** Instance of a "public company" (a specific type of joint-stock company and legal form of enterprise).
*   **Ownership:** Distributed among general public shareholders (individuals, institutional investors, or other entities).
*   **Governance:** Managed through a board of directors elected by its shareholders, maintaining a separation between ownership and control.
*   **Market Status:** Securities are offered for sale to the general public, typically traded openly on a public stock exchange.

## FAQs
**What type of company is Shanghai RAAS Blood Products Co., Ltd.?**
It is classified as a public company, which is a type of joint-stock enterprise that offers its shares to the general public. This structure allows the entity to raise capital from a wide pool of investors rather than relying on a closed group of private backers.

**How is Shanghai RAAS owned and governed?**
The company is owned by its shareholders—individuals or entities that have purchased its publicly traded securities. Governance is handled by a board of directors elected by these shareholders, ensuring a classic corporate separation of ownership and control.

**Is Shanghai RAAS Blood Products Co., Ltd. a state-owned enterprise?**
No, as a public company, it is distinctly different from a "public enterprise" or "government agency." Its ownership is determined by public shareholders rather than the state.

## Why It Matters
As a publicly traded entity, Shanghai RAAS Blood Products Co., Ltd. is integrated into the fundamental pillars of modern capitalism. This corporate structure allows the enterprise to facilitate large-scale capital formation for business expansion and operational development. By being publicly listed, it provides liquidity for investors, allowing them to easily buy and sell ownership stakes. Furthermore, its status requires adherence to strict regulatory disclosure and reporting standards, which promotes transparency and trust for the general public and institutional investors.

## Notable For
*   Being a publicly traded enterprise with the Chinese alias 上海莱士.
*   Operating as a joint-stock company, distinguishing it from private companies, state-owned public enterprises, and cooperatives.
*   Having a distributed ownership model that allows any member of the general public to become a shareholder.
*   Being recorded in global knowledge bases with the specific Freebase identifier `/m/0cp7sz5`.

## Body

### Corporate Identity and Classification
Shanghai RAAS Blood Products Co., Ltd. is legally classified as a public company. In corporate terminology, a public company is a distinct legal form of organization and a subclass of an enterprise. Specifically, it operates as a joint-stock company. This designation dictates that the company's ownership is distributed among general public shareholders through securities, distinguishing it fundamentally from private companies. Additionally, it is important to differentiate Shanghai RAAS from a "public enterprise" or government agency; as a public company, it is not a state-owned entity, but rather a corporation governed by public market forces and shareholders. It is also known by its Chinese alias, 上海莱士, and holds the Freebase identifier `/m/0cp7sz5`.

### Capital and Shareholder Structure
The defining feature of Shanghai RAAS as a public company is its ability to raise capital by offering securities—such as stock or bonds—to the general public. This process generally occurs on a public stock exchange. The ownership of the company is held by its shareholders, a group that can include individual retail investors, large institutional investors, or other corporate entities. This structure contrasts with private companies, which rely on a smaller, closed group of investors for funding. The transition to this status typically involves an initial public offering (IPO). 

### Governance and Operational Framework
The governance of Shanghai RAAS follows the classic corporate structure of a public company. Because the company is owned by its shareholders rather than internal management, control and direction are vested in a board of directors. This board is elected by the shareholders to represent their interests. This creates a distinct separation between ownership (the public shareholders) and control (the management and the board of directors).

### Terminology and Global Context
As a public company, Shanghai RAAS operates under a corporate structure recognized globally. The concept of its organizational type is known by several synonymous terms in English, including "publicly traded company," "publicly held company," and "listed company." The underlying corporate structure it utilizes is universally recognized across different linguistic and economic systems, represented internationally by terms such as "compañía de capital abierto" (Spanish), "Publikumsgesellschaft" (German), "公開企業" (Japanese), "上櫃公司" (Chinese), and "публичное акционерное общество, ПАО" (Russian).